First Time Loading...

Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 14.96 CHF -1.58%
Updated: Apr 19, 2024

Intrinsic Value

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. [ Read More ]

The intrinsic value of one MEDX stock under the Base Case scenario is 29.11 CHF. Compared to the current market price of 14.96 CHF, Medmix Ltd is Undervalued by 49%.

Key Points:
MEDX Intrinsic Value
Base Case
29.11 CHF
Undervaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medmix Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MEDX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medmix Ltd

Provide an overview of the primary business activities
of Medmix Ltd.

What unique competitive advantages
does Medmix Ltd hold over its rivals?

What risks and challenges
does Medmix Ltd face in the near future?

Summarize the latest earnings call
of Medmix Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medmix Ltd.

Provide P/S
for Medmix Ltd.

Provide P/E
for Medmix Ltd.

Provide P/OCF
for Medmix Ltd.

Provide P/FCFE
for Medmix Ltd.

Provide P/B
for Medmix Ltd.

Provide EV/S
for Medmix Ltd.

Provide EV/GP
for Medmix Ltd.

Provide EV/EBITDA
for Medmix Ltd.

Provide EV/EBIT
for Medmix Ltd.

Provide EV/OCF
for Medmix Ltd.

Provide EV/FCFF
for Medmix Ltd.

Provide EV/IC
for Medmix Ltd.

Show me price targets
for Medmix Ltd made by professional analysts.

What are the Revenue projections
for Medmix Ltd?

How accurate were the past Revenue estimates
for Medmix Ltd?

What are the Net Income projections
for Medmix Ltd?

How accurate were the past Net Income estimates
for Medmix Ltd?

What are the EPS projections
for Medmix Ltd?

How accurate were the past EPS estimates
for Medmix Ltd?

What are the EBIT projections
for Medmix Ltd?

How accurate were the past EBIT estimates
for Medmix Ltd?

Compare the revenue forecasts
for Medmix Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medmix Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medmix Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medmix Ltd compared to its peers.

Compare the P/E ratios
of Medmix Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Medmix Ltd with its peers.

Analyze the financial leverage
of Medmix Ltd compared to its main competitors.

Show all profitability ratios
for Medmix Ltd.

Provide ROE
for Medmix Ltd.

Provide ROA
for Medmix Ltd.

Provide ROIC
for Medmix Ltd.

Provide ROCE
for Medmix Ltd.

Provide Gross Margin
for Medmix Ltd.

Provide Operating Margin
for Medmix Ltd.

Provide Net Margin
for Medmix Ltd.

Provide FCF Margin
for Medmix Ltd.

Show all solvency ratios
for Medmix Ltd.

Provide D/E Ratio
for Medmix Ltd.

Provide D/A Ratio
for Medmix Ltd.

Provide Interest Coverage Ratio
for Medmix Ltd.

Provide Altman Z-Score Ratio
for Medmix Ltd.

Provide Quick Ratio
for Medmix Ltd.

Provide Current Ratio
for Medmix Ltd.

Provide Cash Ratio
for Medmix Ltd.

What is the historical Revenue growth
over the last 5 years for Medmix Ltd?

What is the historical Net Income growth
over the last 5 years for Medmix Ltd?

What is the current Free Cash Flow
of Medmix Ltd?

Financials

Balance Sheet Decomposition
Medmix Ltd

Current Assets 340.4m
Cash & Short-Term Investments 152.7m
Receivables 86.9m
Other Current Assets 100.8m
Non-Current Assets 631.2m
Long-Term Investments 8.4m
PP&E 251m
Intangibles 363.8m
Other Non-Current Assets 8m
Current Liabilities 147.6m
Accounts Payable 65.7m
Other Current Liabilities 81.9m
Non-Current Liabilities 337.1m
Long-Term Debt 306.6m
Other Non-Current Liabilities 30.5m
Efficiency

Earnings Waterfall
Medmix Ltd

Revenue
474.6m CHF
Cost of Revenue
-315.1m CHF
Gross Profit
159.5m CHF
Operating Expenses
-136.4m CHF
Operating Income
23.1m CHF
Other Expenses
-28m CHF
Net Income
-4.9m CHF

Free Cash Flow Analysis
Medmix Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

MEDX Profitability Score
Profitability Due Diligence

Medmix Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive Revenue Growth Forecast
Positive Operating Income
49/100
Profitability
Score

Medmix Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

MEDX Solvency Score
Solvency Due Diligence

Medmix Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Average Altman Z-Score
50/100
Solvency
Score

Medmix Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDX Price Targets Summary
Medmix Ltd

Wall Street analysts forecast MEDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDX is 30.6 CHF with a low forecast of 30.3 CHF and a high forecast of 31.5 CHF.

Lowest
Price Target
30.3 CHF
103% Upside
Average
Price Target
30.6 CHF
105% Upside
Highest
Price Target
31.5 CHF
111% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MEDX Price
Medmix Ltd

1M 1M
-3%
6M 6M
-30%
1Y 1Y
-28%
3Y 3Y
-65%
5Y 5Y
-65%
10Y 10Y
-65%
Annual Price Range
14.96
52w Low
14.66
52w High
26.4
Price Metrics
Average Annual Return -28.42%
Standard Deviation of Annual Returns 46.17%
Max Drawdown -68%
Shares Statistics
Market Capitalization 611.5m CHF
Shares Outstanding 40 781 847
Percentage of Shares Shorted
N/A

MEDX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medmix Ltd Logo
Medmix Ltd

Country

Switzerland

Industry

Health Care

Market Cap

611.5m CHF

Dividend Yield

3.34%

Description

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

Contact

ZUG
Zug
Dammstrasse 19
+41417237300
https://www.medmix.ch

IPO

-

Employees

2 101

Officers

Chief Executive Officer
Mr. Girts Cimermans
Chief Financial Officer
Ms. Jennifer Dean
Head of M&A, Strategy & Investor Relations
Ms. Sheel Gill
Chief Legal Officer, Company Secretary & Head of Corporate Affairs
Mr. Schops Xavier
Chief Human Resources, Sustainability & Communications Officer
Ms. Itee Satpathy

See Also

Discover More
What is the Intrinsic Value of one MEDX stock?

The intrinsic value of one MEDX stock under the Base Case scenario is 29.11 CHF.

Is MEDX stock undervalued or overvalued?

Compared to the current market price of 14.96 CHF, Medmix Ltd is Undervalued by 49%.